Literature DB >> 1740370

Electrode comparison in pattern electroretinography.

T C Prager1, N Saad, F C Schweitzer, C A Garcia, G B Arden.   

Abstract

In recent years, there has been great interest in recording the pattern electroretinogram (PERG) in glaucomatous and diabetic populations. The Dawson, Trick, and Litzkow thread electrode (DTLTE) and the gold foil electrode (GFE), commonly used for recording PERGs, were compared for variations in amplitude of response, test-retest variability, and patient comfort. Two study centers collected data on a total of 32 normal subjects. The subjects from the London center showed a slight (but not significant) preference for the DTLTE, and the Houston subjects also found the DTLTE to be significantly more comfortable (chi-square = 39, P less than 0.001). In both study groups, the GFE was found to produce a statistically larger amplitude of response than that obtained with the DTLTE. Significant differences were found regardless of the slow (transient, 3.1 Hz; F = 6.24; P = 0.0192) or fast (steady state, 8.3 Hz; F = 18.38; P = 0.0001) stimulus-presentation rate. Larger differences between the two electrodes occurred under steady-state conditions. Although there is no consensus as to the optimum recording conditions to obtain the subtle PERG, it appears the the GFE records larger responses than the DTLTE. However, test-retest data confirmed that the GFE records twice the amplitude of the DTLTE, and it also produced twice the variability (average percent difference over time for GFE, 15%; for DTLTE, 8%).

Entities:  

Mesh:

Year:  1992        PMID: 1740370

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Pattern reversal ERG with LED-stimulation using cyclic summation technique.

Authors:  Barbara Link; Anselm Jünemann; Folkert K Horn
Journal:  Doc Ophthalmol       Date:  2006-01       Impact factor: 2.379

2.  Pattern reversal ERG and VEP--comparison of stimulation by LED, monitor and a Maxwellian-view system.

Authors:  Barbara Link; Sylvia Rühl; Andrea Peters; Anselm Jünemann; Folkert K Horn
Journal:  Doc Ophthalmol       Date:  2006-01       Impact factor: 2.379

3.  Amplitude scaling relationships of Burian-Allen, gold foil and Dawson, Trick and Litzkow electrodes.

Authors:  M P Hennessy
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

4.  Influence of simultaneous pattern-reversal electroretinogram recording on visual evoked potentials.

Authors:  Y Matsui; I Saito; S Okinami; S Oono
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

5.  Recording the oscillatory potentials of the electroretinogram with the DTL electrode.

Authors:  P Lachapelle; J Benoit; J M Little; B Lachapelle
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

6.  The gold foil electrode in pattern electroretinography.

Authors:  T C Prager; A M Fea; W E Sponsel; F C Schweitzer; L McNulty; C A Garcia
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

7.  Reproducibility of pattern electroretinogram in glaucoma patients with a range of severity of disease with the new glaucoma paradigm.

Authors:  Marie-Josée Fredette; Douglas R Anderson; Vittorio Porciatti; William Feuer
Journal:  Ophthalmology       Date:  2007-11-05       Impact factor: 12.079

8.  The Gutenberg health study: a five-year prospective analysis of psychosocial working conditions using COPSOQ (Copenhagen psychosocial Questoinnaire) and ERI (effort-reward imbalance).

Authors:  Matthias Nuebling; Janice Hegewald; Karla Romero Starke; Hans-Joachim Lincke; Sylvia Jankowiak; Falk Liebers; Ute Latza; Stephan Letzel; Merle Riechmann-Wolf; Emilio Gianicolo; Manfred Beutel; Norbert Pfeiffer; Klaus Lackner; Thomas Münzel; Philipp S Wild; Andreas Seidler
Journal:  BMC Public Health       Date:  2022-01-06       Impact factor: 3.295

9.  Effects of reference electrode location on monopolar-derived multifocal electroretinograms in cynomolgus monkeys.

Authors:  Charlene B Y Kim; James N VerHoeve; Paul L Kaufman; T Michael Nork
Journal:  Doc Ophthalmol       Date:  2006-03-02       Impact factor: 1.854

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.